Boehringer Ingelheim Pharmaceuticals, Inc. v. United States Department of Health and Human Services

UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., No. 3:23-cv-01103 (MPS) Plaintiff, v. UNITED STATES DEPARTMENT OF HEALTH & HUMAN SERVICES, et al., Defendants. RULING ON MOTIONS FOR SUMMARY JUDGMENT I. INTRODUCTION The plaintiff, Boehringer Ingelheim Pharmaceuticals, Inc. (“BI”), challenges the Inflation Reduction Act’s Drug Price Negotiation Program (the “Program”), alleging that the Program violates its rights under the Due Process Clause, the Takings Clause, the First Amendment, and the Excessive Fines Clause. BI also claims that the Center…